A$0.345 -0.0 -1.4%
Last Trade - 5:10am
| Market Cap | £201.7m |
| Enterprise Value | £238.6m |
| Revenue | £86.7m |
| Position in Universe | 475th / 1835 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 110.8 | 104.5 | 107.5 | 119.5 | 149.2 | 153.8 | 170.1 | 192.1 | +6.8% | ||
| -2.2 | -68.3 | +14.8 | -64.4 | +503.3 | -70.5 | +163.9 | +60.0 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Capitol Health Limited is a provider of diagnostic imaging and related services to the Australian healthcare market. The Company owns and operates clinics throughout Victoria and New South Wales. It is engaged in the acquisition and operation of diagnostic imaging facilities. Trading primarily under its brand Capital Radiology, the Company provides a range of diagnostic imaging services. The Company's services include general X-ray; magnetic resonance imaging (MRI); ultrasound; mammography; Doppler; orthopantomography (OPG); echocardiography; computer tomography (CT); CT Angiography; nuclear medicine; bone densitometry, and fluoroscopy. The Company conducts over one million procedures every year. The Company focuses on delivering a community-based infrastructure for radiologists and related medical practitioners.
| Last Annual | June 30th, 2020 |
| Last Interim | June 30th, 2020 |
| Incorporated | December 1, 2005 |
| Public Since | June 9, 2006 |
| No. of Shareholders: | 5,462 |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | S&P/ASX All Ordinaries , |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 1,022,597,194 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Level 2 288 Victoria Parade, MELBOURNE, 3002, Australia |
| Web | http://www.capitolhealth.com.au/ |
| Phone | +61 3 93483333 |
| Contact | () |
| Auditors | Deloitte Touche Tohmatsu |
As of 5:10am, shares in Capitol Health are trading at A$0.345, giving the company a market capitalisation of £201.7m. This share price information is delayed by 15 minutes.
Shares in Capitol Health are currently trading at A$0.345 and the price has moved by 20.69% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Capitol Health price has moved by 15.34% over the past year.
Of the analysts with advisory recommendations for Capitol Health, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Capitol Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Capitol Health is scheduled to issue upcoming financial results on the following dates:
The Capitol Health dividend yield is 2.43% based on the trailing twelve month period.
Last year, Capitol Health paid a total dividend of 0.01, and it currently has a trailing dividend yield of 2.43%. Looking ahead, shares in Capitol Health are due to go ex-dividend on 2021-03-04 and the next dividend pay date is 2021-04-01.
Capitol Health are due to go ex-dividend on 2021-03-04 and the next dividend pay date is 2021-04-01. The historic dividend yield on Capitol Health shares is currently 2.43%.
To buy shares in Capitol Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Capitol Health are currently trading at A$0.345, giving the company a market capitalisation of £201.7m.
Here are the trading details for Capitol Health:
Based on an overall assessment of its quality, value and momentum, Capitol Health is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Capitol Health are currently priced at A$0.345. At that level they are trading at 6.29% premium to the analyst consensus target price of 0.00.
Analysts covering Capitol Health currently have a consensus Earnings Per Share (EPS) forecast of 0.01 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Capitol Health. Over the past six months, the relative strength of its shares against the market has been 23.06%. At the current price of A$0.345, shares in Capitol Health are trading at 39.69% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Capitol Health PE ratio based on its reported earnings over the past 12 months is 92.35. The shares are currently trading at A$0.345.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Capitol Health's management team is headed by:
Here are the top five shareholders of Capitol Health based on the size of their shareholding:
